BDBM323235 N-[(R)-1-(4-methoxybenzyl)-2-oxo-2-(3-pentyl-3-phenylazetidin-1-yl)ethyl]-3-(3-methyl-3H-imidazol-4-yl)propionamide::US9630949, 64

SMILES CCCCCC1(CN(C1)C(=O)[C@@H](Cc1ccc(OC)cc1)NC(=O)CCc1cncn1C)c1ccccc1

InChI Key InChIKey=IVHKXENLVMUQSX-MUUNZHRXSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 323235   

TargetMelanocortin receptor 4(Homo sapiens (Human))
Galderma Research & Development

US Patent
LigandPNGBDBM323235(N-[(R)-1-(4-methoxybenzyl)-2-oxo-2-(3-pentyl-3-phe...)
Affinity DataEC50:  500nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Galderma Research & Development

US Patent
LigandPNGBDBM323235(N-[(R)-1-(4-methoxybenzyl)-2-oxo-2-(3-pentyl-3-phe...)
Affinity DataEC50:  2.00E+3nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent